We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing

By LabMedica International staff writers
Posted on 01 Mar 2023
Print article
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)

The global urinalysis market is projected to grow at a CAGR of 6.7% from USD 1.87 billion in 2021 to USD 2.87 billion by 2030, driven by the rising incidence of kidney and urinary tract disorders, growing demand for point-of-care diagnostic testing, increase in aging population and higher healthcare expenditure. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are linked to kidney and urinary tract disorders, accompanied by technological advancements in urinalysis testing equipment, such as the development of automated urinalysis systems, is expected to fuel market growth.

These are the latest findings of Emergen Research (Vancover, BC, Canada), a market research and consulting company.

The increasing prevalence of kidney diseases and urinary tract infections, particularly among elderly individuals, is a key factor driving the urinalysis market growth. This has been accompanied by the rising occurrences of chronic conditions like diabetes and hypertension, leading to higher incidences of kidney and urinary tract conditions. Additionally, there is an increase in demand for point-of-care diagnostic tests, spurring the development of sophisticated urinalysis testing devices. These devices deliver accurate results quickly, making them a great option for use in ERs, outpatient clinics and other healthcare settings. Technology has also enabled the production of automated urinalysis systems which provide fast and precise results, making them perfect for high-throughput clinical laboratories.

Nevertheless, the market growth could be hindered by the high costs of automated urinalysis systems and other diagnostic testing devices. Additionally, a lack of skilled professionals to carry out diagnostic tests, especially in developing countries, could also impede market growth. Inaccurate results obtained from some urinalysis tests which can lead to misdiagnosis and inadequate treatment can also have a negative impact on market growth. Moreover, the absence of standardization in urinalysis testing processes could affect market growth, as different methods can result in different outcomes, making it difficult to compare results from different labs.

Currently, the urinalysis market is experiencing several trends and innovations including the emergence of advanced urinalysis testing devices and the growing use of point-of-care diagnostic tests. The use of AI and machine learning for urinalysis testing is also a trend that is likely to become more popular in the future. Furthermore, with the increasing demand for easy-to-use portable urinalysis test equipment, particularly in low-income settings, manufacturers are producing innovative devices that are cost-effective and require minimal training to operate.

Geographically, North America is expected to hold the largest revenue share in the global urinalysis market during the forecast period due to the rising prevalence of chronic renal disease, hypertension and diabetes, well-established sophisticated healthcare systems, and significant healthcare expenditure in the region. The European urinalysis market is expected to register a steady revenue growth over the forecast period owing to beneficial reimbursement policies and government guidelines and regulations, as well as developed healthcare infrastructure in the region. The Asia Pacific urinalysis market is expected to register a high revenue growth over the forecast period, thanks to the rapidly developing healthcare industry and increasing investments by key market players.

Related Links:
Emergen Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more